Critical nodes in signalling pathways: insights into insulin action
The DOI matches its Crossref record; 127 of the 129 references it cites were found in a registry or an index.
Abstract
Physiologically important cell-signalling networks are complex, and contain several points of regulation, signal divergence and crosstalk with other signalling cascades. Here, we use the concept of 'critical nodes' to define the important junctions in these pathways and illustrate their unique role using insulin signalling as a model system.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In skeletal muscle, insulin binds to the insulin receptor leading to phosphorylation of three key tyrosine molecules on the insulin receptor. Once the insulin receptor has been phosphorylated, insulin receptor substrate (IRS)-1 moves to the cell membrane and becomes phosphorylated on contiguous tyrosine molecules.”
From Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes (2009) · cites this paper as [25]
In the citing paper
“Reduced phosphorylation of the PI3K/Akt pathway is a hallmark of IR in PCOS patients10–12.”
From Efficacy and safety of GLP-1 receptor agonists on weight management and metabolic parameters in PCOS women: a meta-analysis of randomized controlled trials (2025) · cites this paper as [10]
In the citing paper
“Given that insulin resistance (IR) is widely recognized as the key underlying mechanism of metabolic syndrome, it is reasonable to consider IR as a central factor in the pathogenesis of MASLD, which can be viewed as the hepatic manifestation of metabolic syndrome [2,9-12].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [11]
Citations
Cites
2 retracted
Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism
Taniguchi, C. M., Ueki, K., & Kahn, C. R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23187 · Cited by 272
Self-citationRetractedUeki, K., Fruman, D. A., Yballe, C. M., Fasshauer, M., Klein, J., Asano, T., Cantley, L. C., & Kahn, C. R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305602200 · Cited by 208
Self-citationRetractedPhosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216
Signal transduction by receptors with tyrosine kinase activity
Ullrich, A., & Schlessinger, J. (1990) · Cell · doi:10.1016/0092-8674(90)90801-k · Cited by 5,435 · cited 2×
“The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307).”
BackgroundInhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244
A central role for JNK in obesity and insulin resistance
Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., Karin, M., & Hotamisligil, G. S. (2002) · Nature · doi:10.1038/nature01137 · Cited by 3,359 · cited 1×
“For instance, the phosphorylation of Ser307 of IRS1, which is located in the PTB domain, has been correlated with negative regulation of insulin signallin”
BackgroundAlessi, D. R., James, S. R., Downes, C. P., Holmes, A. B., Gaffney, P. R. J., Reese, C. B., & Cohen, P. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00122-9 · Cited by 2,826
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
Cai, D., Yuan, M., Frantz, D. F., Melendez, P. A., Hansen, L., Lee, J., & Shoelson, S. E. (2005) · Nature Medicine · doi:10.1038/nm1166 · Cited by 2,245 · cited 1×
“Recently, the activation of nuclear factor (NF)-κB-mediated pathways also have been shown to inhibit insulin signalling through enhanced serine phosphorylation of IRS1 (Ref”
BackgroundElchebly, M., Payette, P., Michaliszyn, E., Cromlish, W., Collins, S., Loy, A. L., Normandin, D., Cheng, A., Himms-Hagen, J., Chan, C.-C., et al. (1999) · Science · doi:10.1126/science.283.5407.1544 · Cited by 2,210
Phosphatidylinositol-3-OH kinase direct target of Ras
Rodriguez-Viciana, P., Warne, P. H., Dhand, R., Vanhaesebroeck, B., Gout, I., Fry, M. J., Waterfield, M. D., & Downward, J. (1994) · Nature · doi:10.1038/370527a0 · Cited by 1,954 · cited 1×
“Also, the p85/p110–PI3K complex binds to Ras, linking two pathways that are normally considered to be distinc”
Background
Cited by
Items 801–900 of 1,013
Current Studies on Molecular Mechanisms of Insulin Resistance
Pei, J., Wang, B., & Wang, D. (2022) · Journal of Diabetes Research · doi:10.1155/2022/1863429 · Cited by 74
“On activation of IR, these sites can be phosphorylated and bind to proteins with the Src homology domain 2 (SH2), such as the p85 subunit of the PI3K protein, Grb-2 protein, and the tyrosine protein phosphorylase SHP-2 [53].”
BackgroundCHEN, L.-N., LYU, J., YANG, X.-F., JI, W.-J., YUAN, B.-X., CHEN, M.-X., MA, X., & WANG, B. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1453 · Cited by 50
“The InsR substrate family, such as IRS-1 and IRS-2, is phosphorylated and combines with the regulatory subunit of PI3K and passes insulin signaling to the protein kinase B (Akt) molecule, leading to the induction of a variety of insulin bioactivities, thus improving insulin resistance (11,40-43).”
Hepatic Src Homology Phosphatase 2 Regulates Energy Balance in Mice
Nagata, N., Matsuo, K., Bettaieb, A., Bakke, J., Matsuo, I., Graham, J. L., Xi, Y., Liu, S., Tomilov, A. A., Tomilova, N. B., et al. (2012) · Endocrinology · doi:10.1210/en.2012-1406 · Cited by 51
Li, M., Li, J., Liu, L., Li, W., Yang, Y., & Yuan, J. X. (2013) · Cancers · doi:10.3390/cancers5041306 · Cited by 59
PP2A inhibition results in hepatic insulin resistance despite Akt2 activation
Galbo, T., Perry, R. J., Nishimura, E., Samuel, V. T., Quistorff, B., & Shulman, G. I. (2013) · Aging · doi:10.18632/aging.100611 · Cited by 50
“Akt is a key signaling node in hepatic insulin action [5] and especially the Akt2 isoform appears to be critical for insulin action on glucose metabolism in vivo [6].”
BackgroundKuai, M., Li, Y., Sun, X., Ma, Z., Lin, C., Yi, J., Lu, Y., Chen, Q., Wu, X., Kong, X., et al. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.10.101 · Cited by 52
The Evolving Importance of Insulin Signaling in Podocyte Health and Disease
Lay, A. C., & Coward, R. J. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00693 · Cited by 54
SnapShot: Insulin Signaling Pathways
Kadowaki, T., Ueki, K., Yamauchi, T., & Kubota, N. (2012) · Cell · doi:10.1016/j.cell.2012.01.034 · Cited by 56
Insulin Regulation of Hepatic Lipid Homeostasis
Uehara, K., Santoleri, D., Whitlock, A. E. G., & Titchenell, P. M. (2023) · Comprehensive Physiology · doi:10.1002/cphy.c220015 · Cited by 49
“Upon PIP 3 generation, 3-phosphoinositide-dependent protein kinase-1 (PDK1) is recruited leading to the phosphorylation of AKT, otherwise known as protein kinase B (PKB), specifically at the Thr308 site (318).”
Metformin: review of epidemiology and mechanisms of action in pancreatic cancer
Eibl, G., & Rozengurt, E. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-09977-z · Cited by 55
Mechanistic insights into insulin resistance in the genetic era
Parker, V. E. R., Savage, D. B., O’Rahilly, S., & Semple, R. K. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03463.x · Cited by 49
Gu, S., Lin, J., & Lin, P. (2009) · Journal of Insect Physiology · doi:10.1016/j.jinsphys.2009.09.008 · Cited by 49
FGT-1 is the major glucose transporter in C. elegans and is central to aging pathways
Feng, Y., Williams, B. G., Koumanov, F., Wolstenholme, A. J., & Holman, G. D. (2013) · Biochemical Journal · doi:10.1042/bj20131101 · Cited by 51
Bcl10 Links Saturated Fat Overnutrition with Hepatocellular NF-κB Activation and Insulin Resistance
Beek, M. V., Oravecz-Wilson, K. I., Delekta, P. C., Gu, S., Li, X., Jin, X., Apel, I. J., Konkle, K. S., Feng, Y., Teitelbaum, D. H., et al. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.04.006 · Cited by 51
“In contrast, siRNA-mediated depletion of Bcl10 did reverse the palmitate-dependent inhibition, restoring insulin sensitivity to the cells as measured by Akt phosphorylation (Figure 4B).”
InfluentialAhmad, F., Lindh, R., Tang, Y., Ruishalme, I., Öst, A., Sahachartsiri, B., Strålfors, P., Degerman, E., & Manganiello, V. (2009) · Biochemical Journal · doi:10.1042/bj20090842 · Cited by 50
Muñoz, M. C., Giani, J. F., Mayer, M. A., Toblli, J. E., Turyn, D., & Dominici, F. P. (2009) · Journal of Endocrinology · doi:10.1677/joe-08-0276 · Cited by 49
“In fact, impaired activation of IR associated with excessive Ser/Thr phosphorylation has been reported in animal models of insulin resistance as well as in certain types of insulin-resistant states in humans (Li et al. 2002, Johnston et al. 2003, Taniguchi et al. 2006, Youngren 2007).”
BackgroundRole of Phosphatidylinositol 3,4,5-Trisphosphate in Cell Signaling
Riehle, R. D., Cornea, S., & Degterev, A. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-6331-9_7 · Cited by 57
Shen, X., Zhou, N., Mi, L., Hu, Z., Wang, L., Liu, X., & Zhang, S. (2017) · Drug Design Development and Therapy · doi:10.2147/dddt.s127010 · Cited by 49
Polycystic Ovary Syndrome: Insights into the Therapeutic Approach with Inositols
Sortino, M. A., Salomone, S., Carruba, M. O., & Drago, F. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00341 · Cited by 49
“One of the main target of IRS is PI3K, which is involved in the phosphorylation of Akt, a protein kinase that finally leads to an increase in the translocation of glucose transporter into the plasma membrane (Taniguchi et al., 2006).”
BackgroundHepatocyte Ploidy Is a Diversity Factor for Liver Homeostasis
Kreutz, C., MacNelly, S., Follo, M., Wäldin, A., Binninger-Lacour, P., Timmer, J., & Bartolomé-Rodríguez, M. M. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00862 · Cited by 50
“At the hepatocellular level this is mediated by activation of the insulin signaling pathway, initiated by binding of insulin to the membrane-associated IR and followed by the activities of a complex signaling network mediating their metabolic actions (Taniguchi et al., 2006).”
BackgroundKang, J. K., Kim, O., Hur, J., Yu, S. H., Lamichhane, S., Lee, J. W., Ojha, U., Hong, J. H., Lee, C.-S., Cha, J.-Y., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1706489114 · Cited by 53
“(E) Schematic representation of electrostatic interactions between the PH domain of Akt (Protein Data Bank accession code:1H10) and Ins(1,3,4,5)P4.”
BackgroundInfluentialInsulin does not regulate glucose transport and metabolism in human endothelium
Artwohl, M., Brunmair, B., Fürnsinn, C., Hölzenbein, T., Rainer, G., Freudenthaler, A., Porod, E. M., Huttary, N., & Baumgartner‐Parzer, S. M. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01838.x · Cited by 48
Mack, E. M., Smith, J. E., Kurz, S. G., & Wood, J. R. (2012) · Reproduction · doi:10.1530/rep-12-0225 · Cited by 49
“These actions of IGF1 are mediated by the IGF1R, which stimulates phosphorylation of several downstream signaling factors including Erk1/2 and Akt (Suzuki et al. 2004, Taniguchi et al. 2006, Pavelic et al. 2007).”
BackgroundPrimary cilia-dependent lipid raft/caveolin dynamics regulate adipogenesis
Yamakawa, D., Katoh, D., Kasahara, K., Shiromizu, T., Matsuyama, M., Matsuda, C., Maeno, Y., Watanabe, M., Nishimura, Y., & Inagaki, M. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108817 · Cited by 53
Agarwal, S., Singh, V., & Chauhan, K. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.2024130 · Cited by 61
Metabolic Regulation of Mitochondrial Protein Biogenesis from a Neuronal Perspective
Hees, J. T., & Harbauer, A. B. (2022) · Biomolecules · doi:10.3390/biom12111595 · Cited by 57
“the phosphoinositide 3-kinase (PI3K)-dependent activation of AKT [28].”
BackgroundWang, W., Yang, W., Dai, Y. M., Liu, J., & Chen, Z. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c08835 · Cited by 54
Developmental Pathways Hijacked by Osteosarcoma
Mortus, J., Zhang, Y., & Hughes, D. P. M. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-04843-7_5 · Cited by 49
New Opportunities: Harnessing Induced Pluripotency for Discovery in Diabetes and Metabolism
Teo, A. K. K., Wagers, A. J., & Kulkarni, R. N. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.08.010 · Cited by 50
Quantifying insulin receptor isoform expression in FFPE breast tumors
Harrington, S. C., Weroha, S. J., Reynolds, C. A., Suman, V. J., Lingle, W. L., & Haluska, P. (2012) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2012.04.001 · Cited by 53
“As a homodimer, the full length isoform, InsR-B (+exon 11), binds insulin to maintain glucose metabolism and transport but can induce proliferative and pro-survival signaling in hyperinsulinemic conditions [3–6].”
BackgroundGu, Y., Ande, S. R., & Mishra, S. (2010) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.09.024 · Cited by 49
Wu, W. L., Gan, W., Tong, M., Li, X. L., Dai, J.-Z., Zhang, C. M., & Guo, X. (2010) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2010.11.165 · Cited by 48
Muscle Insulin Resistance and the Inflamed Microvasculature: Fire from Within
Liu, J., & Liu, Z. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030562 · Cited by 50
“Mounting evidence has confirmed that insulin, in addition to stimulating tissue glucose uptake and use [6], is also a vascular hormone that regulates vascular tone and tissue perfusion [7].”
BackgroundOjha, A., Ojha, U., Mohammed, R., Chandrashekar, A., & Ojha, H. (2019) · Clinical Pharmacology Advances and Applications · doi:10.2147/cpaa.s202614 · Cited by 70
“The effects of insulin are mediated by binding to its specific tyrosine kinase transmembrane receptor.(29) The insulin receptor (IR) is a tetrameric protein with two extracellular α-subunits and two intracellular β-subunits.”
Khat‐udomkiri, N., Toejing, P., Sirilun, S., Chaiyasut, C., & Lailerd, N. (2019) · Food Science & Nutrition · doi:10.1002/fsn3.1327 · Cited by 51
Cong, X. X., Gao, X. K., Rao, X. S., Wen, J., Liu, X. C., Shi, Y. P., He, M. Y., Shen, W., Shen, Y. L., Ouyang, H., et al. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-0508-1 · Cited by 49
Selvaraj, J., Sathish, S., Mayilvanan, C., & Balasubramanian, K. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-012-1452-2 · Cited by 47
“by insulin binding to its cell surface receptor, followed by receptor autophosphorylation, and activation of receptor tyrosine kinases, which results in tyrosine phosphorylation of insulin receptor substrates (IRSs) including IRS-1, IRS2, IRS-3, IRS-4, growth factor receptor-bound protein-2 associated binding protein-…”
BackgroundA new mathematical approach for qualitative modeling of the insulin-TOR-MAPK network
Nijhout, H. F., & Callier, V. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00245 · Cited by 49
“Biochemically, PI3K becomes activated when it interacts with specific phosphotyrosine motifs in the IRS (Taniguchi et al., 2006).”
BackgroundInfluentialArlien-Søborg, M. C., Dal, J., Madsen, M. A., Høgild, M. L., Hjelholt, A. J., Pedersen, S. B., Møller, N., Jessen, N., & Jørgensen, J. O. L. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103763 · Cited by 46
Regazzetti, C., Dumas, K., MARCHAND‐BRUSTEL, Y. L., Peraldi, P., Tanti, J., & Giorgetti‐Peraldi, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052154 · Cited by 52
“Activation of insulin receptor leads to phosphorylation of substrates such as IRS and Shc triggering PI-3-kinase/PKB and Ras-ERK pathways [12].”
BackgroundNOD1 activation induces innate immune responses and insulin resistance in human adipocytes
Zhou, Y.-J., Zhou, H., Li, Y., & Song, Y.-L. (2012) · Diabetes & Metabolism · doi:10.1016/j.diabet.2012.08.001 · Cited by 51
Inputs and outputs of insulin receptor
Du, Y., & Wei, T. (2014) · Protein & Cell · doi:10.1007/s13238-014-0030-7 · Cited by 52
“The classical insulin signaling pathway is initiated by the binding of insulin to the insulin receptor (IR) and the subsequent activation of insulin receptor substrate (IRS) proteins (Taniguchi et al., 2006).”
PI3K keeps the balance between metabolism and cancer
Braccini, L., Ciraolo, E., Martini, M., Pirali, T., Germena, G., Rolfo, K., & Hirsch, E. (2012) · Advances in Biological Regulation · doi:10.1016/j.jbior.2012.04.002 · Cited by 55
Agouni, A., Owen, C., Czopek, A., Mody, N., & Delibegović, M. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.09.018 · Cited by 48
Fructose-induced ROS generation impairs glucose utilization in L6 skeletal muscle cells
Jaiswal, N., Maurya, C. K., Pandey, J., Rai, A. K., & Tamrakar, A. K. (2015) · Free Radical Research · doi:10.3109/10715762.2015.1031662 · Cited by 51
IRS posttranslational modifications in regulating insulin signaling
Peng, J., & He, L. (2017) · Journal of Molecular Endocrinology · doi:10.1530/jme-17-0151 · Cited by 52
Duchêne, S., Métayer, S., Cailleau-Audouin, E., Bigot, K., Dupont, J., & Tesseraud, S. (2006) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2006.09.002 · Cited by 54
“p70 S6 kinase (p70S6K) and the translational repressor eukaryotic initiation factor 4E binding protein (4E-BP1) [1–4].”
BackgroundInsulin Signaling in Arthritis
Tripolino, C., Ciaffi, J., Pucino, V., Ruscitti, P., van Leeuwen, N., Borghi, C., Giacomelli, R., Meliconi, R., & Ursini, F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.672519 · Cited by 46
“AKT/PKB regulates five main substrates: 1activates mammalian target of rapamycin (mTOR), responsible of protein synthesis; 2- inhibits glycogen synthase kinase 3 (GSK3), responsible of glycogen synthesis; 3- inhibits forkhead box-containing protein O subfamily (FoxO), involved in the regulation of gluconeogenic and ad…”
BackgroundZhu, Y., Verkhratsky, A., Chen, H., & Yi, C. (2025) · Acta Physiologica · doi:10.1111/apha.14283 · Cited by 54
“87 This further activates signaling pathways mediating mitogenic and metabolic activities.”
Chapter 12 Serine Kinases of Insulin Receptor Substrate Proteins
Boura‐Halfon, S., & Zick, Y. (2009) · Vitamins and hormones · doi:10.1016/s0083-6729(08)00612-2 · Cited by 58
“Insulin is a major anabolic hormone which promotes proper metabolism, energy balance, and maintenance of normal body weight (Taniguchi et al., 2006).”
BackgroundAreca nut procyanidins ameliorate streptozocin-induced hyperglycemia by regulating gluconeogenesis
Huang, P., Chi, C., & Liu, T. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.12.057 · Cited by 46
Regulation of insulin receptor substrate-1 by mTORC2 (mammalian target of rapamycin complex 2)
DeStefano, M. A., & Jacinto, E. (2013) · Biochemical Society Transactions · doi:10.1042/bst20130018 · Cited by 61
Contribution of insulin resistance to vascular dysfunction
Anfossi, G., Russo, I., Doronzo, G., & Trovati, M. (2009) · Archives of Physiology and Biochemistry · doi:10.1080/13813450903136791 · Cited by 54
“…recruitment and activation of downstream signalling molecules, by serving as docking proteins for the p85 regulatory subunit of phosphatidylinositol 3-kinase (PI3-K), the adapter proteins Grb2/Sos, the protein tyrosine phosphatase SHP2 and the tyrosine kinase fyn (Taniguchi et al., 2006).”
BackgroundInfluentialMann, S., Abuelo, Á., Nydam, D. V., Yepes, F. A. L., Overton, T. R., & Wakshlag, J. J. (2016) · Journal of Comparative Physiology B · doi:10.1007/s00360-016-0969-1 · Cited by 50
A Comprehensive Survey of the Roles of Highly Disordered Proteins in Type 2 Diabetes
Du, Z., & Uversky, V. N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102010 · Cited by 48
“IRSs are cytoplasmic scaffolding proteins that mediate signaling between multiple receptor tyrosine kinases (RTK), including the insulin-like growth factor I (IGF1) and insulin receptors, and several other Src homology 2 (SH2) domain-containing proteins [88,89].”
BackgroundStapelberg, N. J. C., Pratt, R., Neumann, D. L., Shum, D., Brandis, S. J., Muthukkumarasamy, V., Stantić, B., Blumenstein, M., & Headrick, J. P. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.03.005 · Cited by 45
Mitochondrial Activity and Skeletal Muscle Insulin Resistance in Kidney Disease
Carré, J. E., & Affourtit, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112751 · Cited by 52
“Insulin activates its receptor (IR) and receptor substrate (IRS1), which comprise a ‘critical node’ in a branched signalling network that allows interaction with other pathways, for example those induced by cytokines [15].”
BackgroundCOL1A1 as a potential new biomarker and therapeutic target for type 2 diabetes
Lin, G., Wan, X., Liu, D., Wen, Y., Yang, C., & Zhao, C. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105436 · Cited by 45
Zhu, K., Meng, Z., Tian, Y., Gu, R. C., Xu, Z.-K., Fang, H., Liu, W., Huang, W., Ding, G., & Xiao, W. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.113991 · Cited by 46
Per1/Per2–Igf2 axis–mediated circadian regulation of myogenic differentiation
Katoku-Kikyo, N., Paatela, E., Houtz, D. L., Lee, B., Munson, D., Wang, X., Hussein, M., Bhatia, J., Lim, S., Yuan, C., et al. (2021) · The Journal of Cell Biology · doi:10.1083/jcb.202101057 · Cited by 48
Li, M., Trapika, I. G. M. G. S. C., Tang, S. Y. S., Cho, J., Qi, Y., Li, C. G., Li, Y., Yao, M., Yang, D., Liu, B., et al. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2021.811870 · Cited by 55
“Insulin regulates a variety of downstream effector such as liver, skeletal muscle, and white adipocytes, via binding to the insulin receptor (INSR) on the plasma membrane of target cells to exert all its known physiological effects (67).”
BackgroundThe metabolic and molecular mechanisms of α‑mangostin in cardiometabolic disorders (Review)
John, O. D., Mushunje, A. T., Surugau, N., & Guad, R. M. (2022) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2022.5176 · Cited by 55
Oh, B. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01067-0 · Cited by 58
Low alpha-synuclein levels in the blood are associated with insulin resistance
Rodriguez‐Araujo, G., Nakagami, H., Takami, Y., Katsuya, T., Akasaka, H., Saitoh, S., Shimamoto, K., Morishita, R., Rakugi, H., & Kaneda, Y. (2015) · Scientific Reports · doi:10.1038/srep12081 · Cited by 53
Yu, Z., Li, D., Ling, W.-H., & Jin, T. (2012) · World Journal of Diabetes · doi:10.4239/wjd.v3.i1.19 · Cited by 48
Jang, E.-H., Ko, J. H., Ahn, C.-W., Lee, H.-H., Shin, J.-K., Chang, S.-J., Park, C., & Kang, J. (2010) · Life Sciences · doi:10.1016/j.lfs.2009.12.012 · Cited by 51
Nagy, L., Docsa, T., Szántó, M., Brunyánszki, A., Hegedűs, C., Márton, J., Kónya, B., Virág, L., Somsák, L., Gergely, P., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069420 · Cited by 52
“regulation of glycogen synthesis by glycogen synthase (GS) and glycogen breakdown by glycogen phosphorylase (GP) through an intricate network of signal transduction pathways related to hormonal signaling [1].”
BackgroundJiang, S., Wang, Y., Ren, D., Li, J., Yuan, G., An, L., Du, P., & Ma, J. (2015) · Pharmaceutical Biology · doi:10.3109/13880209.2014.952838 · Cited by 47
“Thus, JNK-mediated IRS1 phosphorylation disrupts downstream events such as PI3K and Glut4 in the insulin-signaling pathway leading to diabetes mellitus (Draznin, 2006; Taniguchi et al., 2006).”
BackgroundGenetic Ablation of Tau Mitigates Cognitive Impairment Induced by Type 1 Diabetes
Abbondante, S., Baglietto-Vargas, D., Rodriguez-Ortiz, C. J., Estrada-Hernandez, T., Medeiros, R., & LaFerla, F. M. (2014) · The American Journal of Pathology · doi:10.1016/j.ajpath.2013.11.021 · Cited by 45
NUCKS Is a Positive Transcriptional Regulator of Insulin Signaling
Qiu, B., Shi, X., Wong, E. T., Lim, J., Bezzi, M., Low, D., Zhou, Q., Akıncılar, S. C., Lakshmanan, M., Swa, H. L. F., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.05.030 · Cited by 45
“Insulin signaling can be regulated at multiple levels (Taniguchi et al., 2006), with transcriptional control, microRNA-mediated posttranscriptional control (Trajkovski et al., 2011), posttranslational modifications (Zick, 2005), changes in subcellular localization (Inoue et al., 1998), protein…”
InfluentialYu, J., Xiao, F., Guo, Y., Deng, J., Liu, B., Zhang, Q., Li, K., Wang, C., Chen, S., & Guo, F. (2014) · Diabetes · doi:10.2337/db14-1368 · Cited by 47
“The insulin signaling pathway is activated when insulin binds to an IR, resulting in phosphorylation of IRS1 and consequent activation of phosphatidylinositol 3-kinase/ PDK1/AKT and GSK3b, key components of insulin signaling (1,41).”
BackgroundThioredoxin reductase 1 suppresses adipocyte differentiation and insulin responsiveness
Peng, X., Giménez-Cassina, A., Petrus, P., Conrad, M., Rydén, M., & Arnér, E. S. J. (2016) · Scientific Reports · doi:10.1038/srep28080 · Cited by 58
β-Adrenergic Receptor and Insulin Resistance in the Heart
Mangmool, S., Denkaew, T., Parichatikanond, W., & Kurose, H. (2016) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2016.128 · Cited by 51
“Binding of insulin to the a subunits of the receptor activates the intracellular tyrosine kinase activity of the b subunits, resulting in transphosphorylation of one b subunit by the other on specific tyrosine residues, and then autophosphorylation at specific sites in the intracellular tail of the receptor which is f…”
InfluentialSong, L., Sun, B., Boersma, G. J., Cordner, Z. A., Yan, J., Moran, T. H., & Tamashiro, K. L. (2017) · Obesity · doi:10.1002/oby.21821 · Cited by 49
Song, L., Liu, J., Shi, T., Zhang, Y., Zhong, X., Cao, X., & Yang, J. (2020) · The FASEB Journal · doi:10.1096/fj.202001639r · Cited by 46
Qi, P., Li, J., Gao, S., Yuan, Y., Sun, Y., Liu, N., Li, Y., Wang, G., Ling, C., & Shi, J. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.589588 · Cited by 65
Arellano-Buendía, A. S., Castañeda-Lara, L. G., Loredo-Mendoza, M. L., García‐Arroyo, F. E., Rojas‐Morales, P., Argüello-García, R., Juárez-Rojas, J. G., Tapia, E., Pedraza‐Chaverrí, J., Sánchez‐Lozada, L. G., et al. (2020) · Antioxidants · doi:10.3390/antiox9111134 · Cited by 49
“In contrast, hyperinsulinemic state downregulates IRS protein expression such as occurs in metabolic syndrome [62].”
BackgroundGong, L., Zou, Z., Liu, L., Guo, S., & Xing, D. (2021) · Aging · doi:10.18632/aging.202760 · Cited by 47
“The glucose transporter GLUT4 is regulated by activated AKT signaling in skeletal muscle [30, 31].”
Growth Hormone and IGF1 Actions in Kidney Development and Function
Gurevich, E., Segev, Y., & Landau, D. (2021) · Cells · doi:10.3390/cells10123371 · Cited by 48
Ding, X., He, X., Tang, B., & Lan, T. (2024) · Chinese Medicine · doi:10.1186/s13020-024-00894-1 · Cited by 52
“Additionally, the interplay between the liver, adipose tissue and the gut contributes to metabolic dysregulation and inflammation in NAFLD P4502E1 [31].”
BackgroundInsulin signalling to the kidney in health and disease
Hale, L. J., & Coward, R. J. (2012) · Clinical Science · doi:10.1042/cs20120378 · Cited by 45
Mitochondrial Akt-regulated mitochondrial apoptosis signaling in cardiac muscle cells
Su, C., Yang, J., Leu, H., Chen, Y., & Wang, P. H. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00455.2011 · Cited by 44
Meng, R., Zhu, D., Bi, Y., Yang, D., & Wang, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053557 · Cited by 46
“The PI3K/Akt pathway is a crucial regulator of glucose transportation, glycolysis, protein synthesis, lipogenesis, glycogen synthesis and gluconeogenesis [11,12].”
BackgroundCheng, P., Chen, Y.-Y., Cheng, W., Lu, P., Chen, H., Chen, B.-R., Yeh, T., Sun, G., Hsiao, M., & Tseng, C.-J. (2015) · Diabetes · doi:10.2337/db14-1439 · Cited by 46
“Insulin can bind to the IR, leading to the autophosphorylation of the b-subunit of the IR at tyrosine residues, which induces the tyrosine phosphorylation of IR substrates (IRSs) (7).”
BackgroundChen, X., Yi, L., Song, S., Wang, L., Liang, Q., Wang, Y., Wu, Y., & Gao, Q. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.05.041 · Cited by 47
Ceramide and sphingosine 1-phosphate in adipose dysfunction
Fang, Z., Pyne, S., & Pyne, N. J. (2019) · Progress in Lipid Research · doi:10.1016/j.plipres.2019.04.001 · Cited by 53
“8 between insulin-, leptin-, insulin growth factor-1- and inflammatory cytokine-mediated signaling pathways to modulate reversible phosphorylation cascades and transcriptional/translational programmes [67,68].”
BackgroundMacrophage Rewiring by Nutrient Associated PI3K Dependent Pathways
Sharif, O., Brunner, J. S., Vogel, A., & Schabbauer, G. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02002 · Cited by 47
Chapter 7 Intracellular Retention and Insulin‐Stimulated Mobilization of GLUT4 Glucose Transporters
Rubin, B. R., & Bogan, J. S. (2009) · Vitamins and hormones · doi:10.1016/s0083-6729(08)00607-9 · Cited by 49
Egawa, T., Tsuda, S., Ma, X., Hamada, T., & Hayashi, T. (2011) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00249.2011 · Cited by 46
“Ser(307) of IRS-1 is located close to the phosphotyrosinebinding domain of IRS-1 (36).”
BackgroundCHO, K.-A., & KANG, P. B. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2276 · Cited by 43
Viswambharan, H., Yuldasheva, N. Y., Sengupta, A., Imrie, H., Gage, M. C., Haywood, N., Walker, A. M. N., Skromna, A., Makova, N., Galloway, S., et al. (2017) · Circulation Research · doi:10.1161/circresaha.116.309678 · Cited by 43
Personalized molecular signatures of insulin resistance and type 2 diabetes
Kjærgaard, J., Stocks, B., Henderson, J., Freemantle, J. B., Rizo‐Roca, D., Puglia, M., Montoya, M. M., Andersson, D. P., Bäckdahl, J., Hogling, D. E., et al. (2025) · Cell · doi:10.1016/j.cell.2025.05.005 · Cited by 59
Kanamarlapudi, V., Thompson, A., Kelly, E., & Bernal, A. L. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.362087 · Cited by 43
The Regulation of the Autophagic Network and Its Implications for Human Disease
Yang, J. H., Carra, S., Zhu, W., & Kampinga, H. H. (2013) · International Journal of Biological Sciences · doi:10.7150/ijbs.6666 · Cited by 49
“As one of the most important signaling pathways in cell metabolism, the Insulin/IGF (insulin-like growth factors) axis is responsible for promotion of cell proliferation and inhibition of cell death, which are mediated mainly by the PI3K–AKT/PKB pathway and the Ras–mitogen-activated protein kinase (MAPK) pathway (75-7…”
Role of E3 ubiquitin ligases in insulin resistance
Yang, X., Xiang, D., & Yang, Y. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12677 · Cited by 43
“Inhibition of Trim32 in normal muscle increased PI3K-AKT-FoxO signalling and enhanced glucose uptake [35].”
BackgroundInfluentialSchwartz, T. S., & Bronikowski, A. M. (2016) · Integrative and Comparative Biology · doi:10.1093/icb/icw046 · Cited by 46
Is p53 Involved in Tissue‐Specific Insulin Resistance Formation?
Strycharz, J., Drzewoski, J., Szemraj, J., & Śliwińska, A. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/9270549 · Cited by 50
“PIP3 is the key lipid signalling intermediate undergoing dephosphorylation by two lipid phosphatases, SHIP2 (SH2-containing inositol 5-phosphatase-2) and PTEN (phosphatase and tensin homolog) [18].”
BackgroundLabaronne, E., Pinteur, C., Véga, N., Pesenti, S., Julien, B., Meugnier, E., Vidal, H., Naville, D., & Magueresse‐Battistoni, B. L. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.04.001 · Cited by 50
Guo, W., Li, D., You, V., Li, W., Hu, B., Zhang, S., Miao, L., Xian, M., Zhu, Y. Z., & Shen, X. (2018) · The FASEB Journal · doi:10.1096/fj.201801894r · Cited by 44
Kurauti, M. A., Soares, G. M., Marmentini, C., Bronczek, G. A., Branco, R. C. S., & Boschero, A. C. (2021) · Vitamins and hormones · doi:10.1016/bs.vh.2020.12.010 · Cited by 53
Metadata
- Authors
- Taniguchi, C. M., Emanuelli, B., & Kahn, C. R.
- Affiliations
- Joslin Diabetes Center (US)
- Corresponding author
- Kahn, C. Ronald
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2006-02-01
- Volume
- 7
- Issue
- 2
- Pages
- 85-96
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W1998493448
- Cited by
- 2,760
- References
- 129
- Citations by year
- 2026: 87 · 2025: 91 · 2024: 97 · 2023: 96 · 2022: 149 · 2021: 144 · 2020: 147 · 2019: 118 · 2018: 156 · 2017: 136 · 2016: 148 · 2015: 177 · 2014: 188 · 2013: 189 · 2012: 181
- FWCI
- 9.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- Funders
- American Diabetes Association
- National Institutes of Health
- Diabetes Research Center
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK031036)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- critical nodes, insulin signaling, signaling networks, signaling crosstalk, signal divergence, insulin resistance, insulin action
- MeSH terms
- Animals, Humans, Insulin, Receptor, Insulin, Signal Transduction, Phosphatidylinositol 3-Kinases, Proto-Oncogene Proteins c-akt
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.